— Know what they know.
Not Investment Advice
Also trades as: ASBPW (NASDAQ) · $vol 0M

ASBP NASDAQ

Aspire Biopharma Holdings, Inc.
1W: +5.5% 1M: -4.7% 3M: +49.3% YTD: -94.7% 1Y: -96.6%
$8.78
+0.66 (+8.13%)
 
Weekly Expected Move ±10.3%
$7 $8 $9 $10 $11
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 40 · $1.0M mcap · 77730 float · 849.83% daily turnover · Short 57% of daily vol

Balance Sheet Trends

Total Assets
$1M +786.7% ▲
3Y CAGR: -83.6%
Total Liabilities
$8M +355.5% ▲
3Y CAGR: -11.6%
Shareholders Equity
-$6M -314.0% ▼
Cash & Investments
$1M +27532.9% ▲
3Y CAGR: +26.4%
Total Debt
$1M +9.3% ▲
Net Debt
$381K -69.8% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025
— Assets —
Cash$497K$11K$4K$1M
Short-Term Investments$0$0$0$0
Cash & ST Investments$497K$11K$4K$1M
Net Receivables$0$0$37K$0
Inventory$0$0$0$253K
Other Current Assets$600K$0-$37K$55K
Total Current Assets$1M$46K$148K$1M
Property, Plant & Equip.$0$0$0$0
Goodwill & Intangibles$0$0$0$0
Long-Term Investments$299M$0$7M$0
Other Non-Current Assets$80K$0-$7M$0
Total Non-Current Assets$299M$0$0$0
Total Assets$300M$46K$148K$1M
— Liabilities —
Accounts Payable$0$173K$310K$1M
Short-Term Debt$0$361K$1M$1M
Deferred Revenue$0$0$0$0
Other Current Liabilities$303K$626$111K$6M
Total Current Liabilities$303K$534K$2M$8M
Long-Term Debt$0$0$0$0
Other Non-Current Liab.$11M$0$0$96K
Total Non-Current Liabilities$11M$0$0$96K
Total Liabilities$11M$534K$2M$8M
— Equity —
Common Stock$299M$22K$22K$353
Retained Earnings-$10M-$1M-$3M-$27M
Accumulated OCI$0$0$0$0
Total Stockholders Equity$289M-$488K-$2M-$6M
Total Liabilities & Equity$300M$46K$148K$1M
— Key Metrics —
Total Debt$0$361K$1M$1M
Net Debt-$497K$349K$1M$381K
Total Investments$299M$0$7M$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms